New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export NVS’s income statement to Excel — free account
Novartis AG
NVSHealthcare Drug Manufacturers General
Novartis AG’s revenue for fiscal 2025 (year ended December 2025) was $56.7 billion, up 9.57% from fiscal 2024.
- Revenue
- +4.67%
- EPS
- −68.8%
- Free cash flow
- −17.8%
- Total debt
- +53.9%
Quarter to September 2026, against a year earlier
152.04
0.83
+0.55%
Follow NVS
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Free cash flow of $17.6B covered $17.0B of dividends and buybacks. Cash fell by $24.0M. What is a cash flow statement?
- Free cash flow
- $17.6B 92.0% of operating cash flow
- Returned to shareholders
- $17.0B 96.6% of free cash flow
- Debt, net
- $2.4B borrowed
- Change in cash
- −$24.0M over the period
| Operating cash flow | 19.1 |
|---|---|
| Capital expenditures | −1.5 |
| Free cash flow | 17.6 |
| Acquisitions, net | −0.2 |
| From investments, net | +1.9 |
| Dividends | −7.8 |
| Buybacks, net | −9.2 |
| Debt raised, net | +2.4 |
| Other | −4.7 |
| Change in cash | 0.0 |
Free cash flow
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $11.5B | $12.6B | $14.3B | $13.6B | $13.6B | $15.1B | $14.2B | $14.5B | $17.6B | $19.1B |
| Capex | −$1.8B | −$1.6B | −$1.2B | −$522M | −$1.2B | −$1.1B | −$758M | −$823M | −$1.3B | −$1.5B |
| Free cash flow | $9.6B | $11.0B | $13.1B | $13.1B | $12.5B | $13.9B | $13.5B | $13.6B | $16.3B | $17.6B |
Figures in billions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
13,967.00 | 11,939.00 | 8,572.00 | 6,049.00 | 24,018.00 | 8,071.00 | 7,147.00 | 12,800.00 | 7,703.00 | 6,698.00 |
Depreciation & Amortization |
5,275.00 | 6,114.00 | 8,383.00 | 6,965.00 | 5,454.95 | 6,129.00 | 5,788.00 | 5,217.00 | 6,076.00 | 6,043.00 |
Non Cash Items (Other) |
2,962.00 | 1,379.00 | (594.00) | 2,792.00 | (8,069.00) | 2,178.00 | 1,415.00 | (4,321.00) | (781.00) | 2,326.00 |
Accounts Receivable Change |
(1,124.00) | (931.00) | (1,504.00) | (589.00) | (389.00) | 137.00 | (980.00) | (544.00) | (204.00) | (229.00) |
Change in inventories |
34.00 | (225.00) | (546.00) | (830.00) | 81.00 | (543.00) | (382.00) | (387.00) | (247.00) | (235.00) |
Accounts Payable Change |
(273.00) | (105.00) | 479.00 | (48.00) | (21.00) | (324.00) | 553.00 | 252.00 | 58.00 | (587.00) |
Change in other assets and liabilities |
(214.00) | 555.00 | 1,202.00 | (796.00) | 570.00 | 439.00 | 1,008.00 | 1,255.00 | 637.00 | 974.00 |
Other operating activities |
(1,483.00) | (1,107.00) | (1,534.00) | (774.00) | (1,119.00) | (2,437.00) | (924.00) | — | (877.00) | (1,536.00) |
Operating Cash Flow |
19,144.00 | 17,619.00 | 14,458.00 | 14,236.00 | 15,071.00 | 13,650.00 | 13,625.00 | 14,272.00 | 12,621.00 | 11,475.00 |
Capital expenditures |
(1,535.00) | (1,280.00) | (823.00) | (758.00) | (1,138.00) | (1,187.00) | (522.00) | (1,152.00) | (1,645.00) | (1,850.00) |
Change in intangibles (net) |
(2,188.00) | (2,368.00) | 262.00 | (1,153.00) | (845.00) | (930.00) | 95.00 | (571.00) | (410.00) | (170.00) |
Net Aquisitions |
(235.00) | (3,911.00) | (4,681.00) | (1,276.00) | 20,102.00 | (10,091.00) | (4,925.00) | (14,684.00) | (784.00) | (765.00) |
Short Term Investments Change (Net) |
1,781.00 | (711.00) | 10,607.00 | 4,662.00 | (14,105.00) | (1,408.00) | 2,333.00 | (1,968.00) | (31.00) | 92.00 |
Long-Term Investments Change (Net) |
93.00 | 764.00 | 231.00 | (6.00) | 251.00 | 493.00 | 850.00 | 12,814.00 | (138.00) | — |
Other investing activities |
(2,793.00) | (7.00) | — | (1.00) | (57.00) | (59.00) | (57.00) | (30.00) | (41.00) | (149.00) |
Investing cash flow |
(4,877.00) | (7,513.00) | 5,596.00 | 1,468.00 | 4,208.00 | (13,182.00) | (2,226.00) | (5,591.00) | (3,119.00) | (3,441.00) |
Repayment/Issuance of Debt (Net) |
2,430.00 | 4,390.00 | (1,935.00) | (2,585.00) | (5,986.00) | 7,072.00 | (4,957.00) | 4,177.00 | 3,990.00 | 2,055.00 |
Equity Repurchase (Common, Net) |
(9,185.00) | (8,301.00) | (8,566.00) | (10,552.00) | (3,004.00) | (2,842.00) | (5,332.00) | (2,036.00) | (5,238.00) | (895.00) |
Dividends Paid (Total) |
(7,818.00) | (7,624.00) | (7,255.00) | (7,506.00) | (7,368.00) | (6,987.00) | (6,645.00) | (6,966.00) | (6,495.00) | (6,475.00) |
Other financial activities |
(294.00) | (207.00) | 3,478.00 | 81.00 | 94.00 | 549.00 | 3,307.00 | 581.00 | 10.00 | 208.00 |
Financing cash flow |
(14,867.00) | (11,742.00) | (14,278.00) | (20,562.00) | (16,264.00) | (2,208.00) | (13,627.00) | (4,244.00) | (7,733.00) | (5,314.00) |
Exchange Rate Adjustment |
576.00 | (298.00) | 100.00 | (32.00) | (266.00) | 286.00 | 69.00 | (26.00) | 84.00 | (387.00) |
Change in Cash |
(24.00) | (1,934.00) | 5,876.00 | (4,890.00) | 2,749.00 | (1,454.00) | (2,159.00) | 4,411.00 | 1,853.00 | 2,333.00 |
Beginning Cash |
11,459.00 | 13,393.00 | 7,517.00 | 12,407.00 | 9,658.00 | 11,112.00 | 13,271.00 | 8,860.00 | 7,007.00 | 4,674.00 |
Ending Cash |
11,435.00 | 11,459.00 | 13,393.00 | 7,517.00 | 12,407.00 | 9,658.00 | 11,112.00 | 13,271.00 | 8,860.00 | 7,007.00 |
Stock Based Compensation |
1,096.00 | 1,044.00 | 865.00 | 791.00 | 736.00 | 738.00 | 758.00 | 673.00 | 683.00 | 671.00 |
Dividends Paid (Common) |
(7,818.00) | (7,624.00) | (7,255.00) | (7,506.00) | (7,368.00) | (6,987.00) | (6,645.00) | (6,966.00) | (6,495.00) | (6,475.00) |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
(1,577.00) | (706.00) | (369.00) | (796.00) | 241.00 | (291.00) | 199.00 | 576.00 | 244.00 | (77.00) |
Investments Change (Net) |
1,874.00 | 53.00 | 10,838.00 | 4,656.00 | (13,854.00) | (915.00) | 3,183.00 | 10,846.00 | (169.00) | 92.00 |
Issuance/Purchase of Shares |
(9,185.00) | (8,301.00) | (8,566.00) | (10,552.00) | (3,004.00) | (2,842.00) | (5,332.00) | (2,036.00) | (5,238.00) | (895.00) |
| Other line items | ||||||||||
Revenue per Employee |
0.75 | 0.68 | 0.61 | 0.43 | 0.51 | 0.47 | 0.47 | 0.37 | 0.41 | 0.40 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026